GOSS Rasio cepet Gossamer Bio, Inc.

The Gossamer Bio, Inc. (GOSS) price chart on the GURU.Markets platform, where the coefficient is 0.53, reflects the dynamics of a company engaged in a fierce battle for the hypertension and asthma treatment market. The business relies on patent protection and the success of a single key molecule, which creates significant risks. Stability is bolstered by the implementation of eco-friendly ESG standards in laboratories and strict adherence to bioethics.

The quick ratio measures the ability of Gossamer Bio, Inc. (GOSS) to cover short-term obligations using its most liquid assets, excluding slow-moving inventories. By analyzing the average quick ratio, an investor assesses the company's financial resilience to external shocks, such as supply chain disruptions and the freezing of international immunological drug research due to geopolitical tensions.